Antiatherogenic Properties of tert-Butylhydroquinone

叔丁基氢醌的抗动脉粥样硬化特性

基本信息

  • 批准号:
    6786512
  • 负责人:
  • 金额:
    $ 10万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-09-15 至 2007-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Atherosclerosis is the underlying cause of most cardiovascular disease and considerable evidence supports the role of hypercholesterolemia as a risk factor for this disease. In preliminary work, we found that tertiary-butyl hydroquinone (TBHQ), at a dose lower than approved for human use, was effective in reducing plasma levels of both total cholesterol and triglycerides in a rat model. TBHQ is phenolic antioxidant commonly used as a food preservative. A patent, "Method for Reducing Blood Cholesterol and/or Blood Triglycerides," was subsequently obtained. The long-term objective of this research proposal is to determine the antiatherogenic potential of TBHQ and advance its commercial development. Our specific aims are to test the efficacy of TBHQ in: (1) reducing aortic atherosclerosis; (2) lowering plasma lipid levels; (3) promoting a less atherogenic lipoprotein profile and; (4) reducing plasma levels of C-reactive protein (CRP). Elevated levels of CRP are a risk factor for cardiovascular disease. In our phase I experiments, we will use the apoE knockout (apoE-/-) mouse model since it has been extensively used to study the antiatherogenic potential of other phenolic antioxidants. Our preliminary market analysis suggests that TBHQ could have a potential market of $100 million per year as a lipid-lowering agent. Commercial development should be accelerated since NIH has already conducted extensive toxicological studies with TBHQ.
描述(申请人提供):动脉粥样硬化是大多数心血管疾病的根本原因,相当多的证据支持高胆固醇血症是这种疾病的危险因素。在初步工作中,我们发现叔丁基对苯二酚(TBHQ)在低于批准的人类使用剂量时,可以有效地降低大鼠模型中总胆固醇和甘油三酯的水平。TBHQ是一种酚类抗氧化剂,通常用作食品防腐剂。随后获得了专利“降低血液胆固醇和/或甘油三酯的方法”。这项研究计划的长期目标是确定TBHQ的抗动脉粥样硬化潜力,并推动其商业化发展。我们的具体目标是测试TBHQ在以下方面的有效性:(1)减少主动脉粥样硬化;(2)降低血脂水平;(3)促进较少的动脉粥样硬化形成脂蛋白;(4)降低血浆C-反应蛋白(CRP)水平。C反应蛋白水平升高是心血管疾病的危险因素。在我们的第一阶段实验中,我们将使用apoE基因敲除(apoE-/-)小鼠模型,因为它已被广泛用于研究其他酚类抗氧化剂的抗动脉粥样硬化潜力。我们的初步市场分析表明,TBHQ作为一种降脂剂,每年可能有1亿美元的潜在市场。应该加快商业开发,因为NIH已经与TBHQ进行了广泛的毒理学研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William L Stone其他文献

Gamma (γ) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (γ) expression in SW 480 human colon cancer cell lines
  • DOI:
    10.1186/1471-2407-3-25
  • 发表时间:
    2003-10-01
  • 期刊:
  • 影响因子:
    3.400
  • 作者:
    Sharon E Campbell;William L Stone;Sarah G Whaley;Min Qui;Koyamangalath Krishnan
  • 通讯作者:
    Koyamangalath Krishnan
912 STUDIES RELATED TO THE CRISIS EPISODES IN SICKLE CELL PATIENTS
  • DOI:
    10.1203/00006450-198504000-00942
  • 发表时间:
    1985-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Saburo Hara;Parimal K Adhikary;Robert E Hardy;Chandradhar Dwivedi;William L Stone;Cynthia Weaver;Carolyn Taylor;Dharmdeo M Singh;Festus O Adebonojo
  • 通讯作者:
    Festus O Adebonojo
THE INFLUENCE OF SURFACTANT ON WATER SOLUBLE ANTIOXIDANTS IN BRONCHOALVEOLAR LAVAGE FROM PREMATURE INFANTS. 1164
  • DOI:
    10.1203/00006450-199604001-01186
  • 发表时间:
    1996-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Des Bharti;William L Stone;Qinglin Tan;Thomas T.S Huang
  • 通讯作者:
    Thomas T.S Huang

William L Stone的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William L Stone', 18)}}的其他基金

ANTIOXIDANTS AND THE KINETICS OF LIPOPROTEIN OXIDATION
抗氧化剂和脂蛋白氧化动力学
  • 批准号:
    2221583
  • 财政年份:
    1992
  • 资助金额:
    $ 10万
  • 项目类别:
MINORITY SCHOOL FACULTY DEVELOPMENT AWARD
少数族裔学校教师发展奖
  • 批准号:
    3088295
  • 财政年份:
    1986
  • 资助金额:
    $ 10万
  • 项目类别:
MINORITY SCHOOL FACULTY DEVELOPMENT AWARD
少数族裔学校教师发展奖
  • 批准号:
    3088294
  • 财政年份:
    1986
  • 资助金额:
    $ 10万
  • 项目类别:
MINORITY SCHOOL FACULTY DEVELOPMENT AWARD
少数族裔学校教师发展奖
  • 批准号:
    3088293
  • 财政年份:
    1986
  • 资助金额:
    $ 10万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了